Saksoft Ltd. Player in computer programming business conducted their conference call today at 11:00 am.
" Addressing sweep digitisation to attain enhance Operational efficiency. "
Here are the key takeaways 😁😁...
Business report
- With strong yearly report, company is positive for future outlook.
- They are doing their best to have a strong team for a scalable sustainable growth.
- Previous M&As done by Company has enhanced their competence to perform their key business efficiently.
- Company has done its best to make sure it's employees are doing well.
- They are still paying salary to the employees who are no more with us.
- They have growth 8% but they accept it is less and will do better to make changes and grow.
- They will hire more and more people in sales and other departments for future business push.
- For business, if they can solve their growth problem in times to come, they will enter into different league as a whole.
Geography breakup
- Company has great presence in USA, Europe and other APAC as well.
- During this period There has been strong demand from Europe.
- Company is more inclined towards more off shore business.
- Company has been able to add two new major clients to their client portfolio with revenue generation capacity of 0.5 to 1 mill dollars.
- Currently they has good client base across different industries like healthcare, Fin-tech, Logistics and many more.
- In which Telecommunication and Fin-tech contribute around 50% of total revenue.
- They are doing best to great better opportunity in key areas.
- Focus on niche areas are also done along side, They knew that they hadn't grown fast and expects to cover that up.
- Company had faced issues in past to add clients, growth has come from growing existing customers.
- there has been 25% growth in telecommunication.
- Their has been a decline in Fin-tech business during this year.
- The Company will do more spending in sales part for better business opportunity.
- BSFI de-growth had been difficult for them as their largest client has opened up an captive in india.
- Company has target market of clients 100 million plus , there is no auction system.
- There has been shift in doing MnA for cash management to growth in scale and size.
- Company has strong hold in us logistics business and expect more from it.
Products
- They have strong service portfolio from conducting software product engineering, Analytics to automation and support services which ever suits for the clients.
- Most of work is done on azure and not on Hana or Oracle for services on cloud.
Financials
- Company has grown its revenue at 7% YoY.
- They have a short fall in their EBITDA margins compare to last year.
- Increase of around 18% has been seen in their Pat levels.
- During this period company has made a grand Increase in its cash position to 90 cr.
- They are able to maintain and grow is dividend on steady basis.
- Margins has been stable for business due to good support from its telecommunications business segment.
- Currency change has impacted business by 3%.
- Company has 5 lakh share in Espo trust, it's relevance has lost, this will be used to bring a float in stock for upcoming period.
- No updates given for buyback, they will do it through proper routes.
- Accretion of 25% is been expected by company which is equal to industry.
For more discussion on Equity research and OI analysis
Alkyl Amines conducted their conference call today at 4 pm.
Here are the key takeaways 😃
Business Updates:
• Much of growth contributors was value growth.
• Around 1/3 growth delivered by volume and 2/3 in volume. There were certain supply chin issue, leading to lower growth ion volume.
Growth:
• Co. is fairly optimistic on volume, with respect to sales in Pharma, as Pharma is going well.
• 3-5 year Volume growth target: 15%+ CAGR.
• There can be mid blip due to expansion.
#Cadila Healthcare conducted their conference call yesterday for Q4 FY2021
"Cadila is 2nd larget growing company in Pharma space"
Here are the key takeaways 😃
Business Updates:
• India business grew 20% (includes human health, consumer wellness, & animal wellness)- 16.4BilRs.
• US (generic and Sepciality)- 16.03Bill Rs. QoQ decline
• Emerging Market growth- 11%: 2.93BilRs Sales.
• Launched 7 new product and approvals of 9 product.
Revenue Mix:
• Human Health (India)- 21% growth (YoY).- 11.04BilRs
• Branded Generic Business grew 24% YoY
• Gained market share in Pain Mgmt, Anti-Effective, Anti-Diabetic.
• Market Share in Gyno, Pain Mgmt, Respiratory was maintained.
• Animal Health- 17% growth.
#SHKhelkar conducted their conference call today at 2:00 PM
"Expected to continue the momentum (~15% growth) and improve the margins"
Here are the key takeaways 😃
Business Updates:
• All the segment grew well. Acquired new customer in the domestic market.
• Net debt reduce by 132cr owing to increase in CF.
• Did the acquisition of Nova in this quarter.
• Co. focus on improving the Cash Flow generation and strengthening Balance Sheet.
Domestic Market (Covid)
• All the domestic segment grew well, and there was no impact on customer side in domestic market.
• Covid did had little impact over the segment, however growth momentum again picked up.
• Expected to growth 12-13% over coming year.
IG Petrochemicals Ltd. Conducted their conference call today at 3:30 pm.
" To become a well diversified chemical company with leadership in PAN* Industry. "
Here are the key takeaways 😁...
Business Overview
- Company has given robust growth in both QoQ and YoY basis.
- They still maintain their position of being the largest manufacturer of phthalic Anhydride (PAN) and maleic anhydride.(MAN)
- With government demand being bullish on downstream products like Paints, Plasticizers, UPR and all , there will be demand of PAN in domestic markets.
- They have a positive correlation with the infrastructure industry leading to a strong demand growth.
Balaji Amines conducted their Conference Call today at 4:00 pm.
Here are the key takeaways 😃
Business Updates:
• EBIDTA growth- 78% Driver were increasing demand and improving price realization.
• Zero debt co. on standalone basis.
• Certain product are now exported to China.
Ethylamines:
• With implementation of new technology the cost of production is expected to lower.
• Demand is India is expected to increase by 12-15% over years.
• Import of Ethylamines is 9,000 Tones in India.
• Majority will be sell directly in market.